Restless legs syndrome: a new entity of neuropathic pain? Treatment with prolonged release oxycodone/naloxone combination

References

• Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisir J. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med. 2003;4:101–119.
   PubMed Web of Science ®Google Scholar
• Allen RP, Picchietti DL, Garcia-Borreguero D, et al. Restless legs syndrome/Willis-Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria – history, rationale, description, and significance. Sleep Med. 2014;15:860–873.
   PubMed Web of Science ®Google Scholar
• Allen RP, Walters AS, Montplaisir J, et al. Restless legs syndrome prevalence and impact: REST general population study. Arch Intern Med. 2005;165:1286–1292.
   PubMed Web of Science ®Google Scholar
• Ondo WG. Restless Legs Syndrome: pathophysiology and treatment. Curr Treat Options Neurol. 2014;16:317–334.
   PubMed Web of Science ®Google Scholar
• Salminen AV, Rimpila V, Polo O. Peripheral hypoxia in restless legs syndrome (Willis-Ekbom disease). Neurology. 2014;82:1856–1861.
   PubMed Web of Science ®Google Scholar
• Trenkwalder C, Paulus W. Why do restless legs occur at rest? – Pathophysiology of neuronal structures in RLS: neurophysiology of RLS (part 2). Clin Neurophysiol. 2004;115:1975–1988.
   PubMed Web of Science ®Google Scholar
• Clemens S, Rye D, Hochman S. Restless legs syndrome: revisiting the dopamine hypothesis from the spinal cord perspective. Neurology. 2006;67:125–130.
   PubMed Web of Science ®Google Scholar
• Karroum EG, Golmard JL, Leu-Semenescu S, Arnulf I. Painful restless legs syndrome: a severe, burning form of the disease. Clin J Pain. 2015;31(5):459–466.
   PubMed Web of Science ®Google Scholar
• Kerr S, McKinon W, Bentley A. Descriptors of restless legs syndrome sensations. Sleep Med. 2012;13:409–413.
   PubMed Web of Science ®Google Scholar
• Winkelmann J, Wetter TC, Collado-Seidel V, et al. Clinical characteristics and frequency of the hereditary restless legs syndrome in a population of 300 patients. Sleep. 2000;23:597–602.
   PubMed Web of Science ®Google Scholar
• Cho YW, Song ML, Earley CJ, Allen RP. Prevalence and clinical characteristics of patients with restless legs syndrome with painful symptoms. Sleep Med. 2015;16:775–778.
   PubMed Web of Science ®Google Scholar
• Bentley AJ, Rosman KD, Mitchell D. Can the sensory symptoms of restless legs syndrome be assessed using a qualitative pain questionnaire? Clin J Pain. 2007;23:62–66.
   Web of Science ®Google Scholar
• Bennett MI, Attal N, Backonja MM, et al. Using screening tools to identify neuropathic pain. Pain. 2007;127:199–203.
   PubMed Web of Science ®Google Scholar
• Gemignani F, Vitetta F, Brindani F, Contini M, Negrotti A. Painful polyneuropathy associated with restless legs syndrome. Clinical features and sensory profile. Sleep Med. 2013;14:79–84.
   PubMed Web of Science ®Google Scholar
• Treede RD, Jensen TS, Campbell JN, et al. Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology. 2008;70:1630–1635.
   PubMed Web of Science ®Google Scholar
• Schattschneider J, Bode A, Wasner G, Binder A, Deuschl G, Baron R. Idiopathic restless legs syndrome: abnormalities in central somatosensory processing. J Neurol. 2004;251:977–982.
   Web of Science ®Google Scholar
• Stiasny-Kolster K, Magerl W, Oertel WH, Möller JC, Treede RD. Static mechanical hyperalgesia without dynamic tactile allodynia in patients with restless legs syndrome. Brain. 2004;127:773–782.
   PubMed Web of Science ®Google Scholar
• Bachmann CG, Rolke R, Scheidt U, et al. Thermal hypoaesthesia differentiates secondary restless legs syndrome associated with small fibre neuropathy from primary restless legs syndrome. Brain. 2010;133:762–770.
   PubMed Web of Science ®Google Scholar
• Stiasny-Kolster K, Pfau DB, Oertel WH, Treede RD, Magerl W. Hyperalgesia and functional sensory loss in restless legs syndrome. Pain. 2013;154:1457–1463.
   Web of Science ®Google Scholar
• Ziegler EA, Magerl W, Meyer RA, Treede R-D. Secondary hyperalgesia to punctate mechanical stimuli: central sensitization to A-fibre nociceptor input. Brain. 1999;122:2245–2257.
   PubMed Web of Science ®Google Scholar
• Garcia-Borreguero D, Ferini-Strambi L, Kohnen R, et al. European guidelines on management of restless legs syndrome: report of a joint task force by the European federation of neurological societies, the European neurological society and the European sleep research society. Eur J Neurol. 2012;19(11):1385–1396.
   Web of Science ®Google Scholar
• Silber MH, Becker PM, Earley C, Garcia-Borreguero D, Ondo WG; Medical Advisory Board of the Willis-Ekbom Disease Foundation. Willis-Ekbom disease foundation revised consensus statement on the management of restless legs syndrome. Mayo Clin Proc. 2013;88(9):977–986.
   Web of Science ®Google Scholar
• Akpinar S. Treatment of restless legs syndrome with levodopa plus benserazide. Arch Neurol. 1982;39:739.
   PubMed Web of Science ®Google Scholar
• Ondo W, Jankovic J. Restless legs syndrome. Clinicoetiologic correlates. Neurology. 1996;47:1435–1441.
   PubMed Web of Science ®Google Scholar
• Allen R. Dopamine and iron in the pathophysiology of restless legs syndrome (RLS). Sleep Med. 2004;5:385–391.
   PubMed Web of Science ®Google Scholar
• Ondo WG, He Y, Rajasekaran S, Le WD. Clinical correlates of 6-hydroxydopamine injections into A11 dopaminergic neurons in rats: a possible model for restless legs syndrome. Mov Disord. 2000;15:154–158.
   PubMed Web of Science ®Google Scholar
• Millan MJ. Descending control of pain. Prog Neurobiol. 2002;66: 355–474.
   PubMed Web of Science ®Google Scholar
• Barraud Q, Obeid I, Aubert I, et al. Neuroanatomical study of the A11 diencephalospinal pathway in the non-human primate. PLoS One. 2010;5(10):e13306.
   Web of Science ®Google Scholar
• Garcia-Borreguero D, Kohnen R, Hogl B, et al. Validation of the Augmentation Severity Rating Scale (ASRS): a multicentric, prospective study with levodopa on restless legs syndrome. Sleep Med. 2007;8(5):455–463.
   Web of Science ®Google Scholar
• Paulus W, Trenkwalder C. Less is more: pathophysiology of dopaminergic-therapy-related augmentation in restless legs syndrome. Lancet Neurol. 2006;5:878–886.
   PubMed Web of Science ®Google Scholar
• Ekbom KA. Restless Legs. Stockholm: Ivar Haeggströms; 1945.
   Google Scholar
• Burhans MS, Dailey C, Beard Z, et al. Iron deficiency: differential effects on monoamine transporters. Nutr Neurosci. 2005;8:31–38.
   PubMed Web of Science ®Google Scholar
• Dooley DJ, Taylor CP, Donevan S, Feltner D. Ca2+ channel alpha2delta ligands: novel modulators of neurotransmission. Trends Pharmacol Sci. 2007;28:75–82.
   PubMed Web of Science ®Google Scholar
• Bauer CS, Nieto-Rostro M, Rahman W, et al. The increased trafficking of the calcium channel subunit a2d-1 to presynaptic terminals in neuropathic pain is inhibited by the a2d ligand pregabalin. J Neurosci. 2009;29:4076–4088.
   PubMed Web of Science ®Google Scholar
• Schomburg ED. Restrictions on the interpretation of spinal reflex modulation in pain and analgesia research. Pain Forum. 1997;6:101–109.
   Google Scholar
• Schomburg ED, Steffens H. Influence of opioids and naloxone on rhythmic motor activity in spinal cats. Exp Brain Res. 1995;103:333–343.
   Web of Science ®Google Scholar
• Fields HL, Emson PC, Leigh BK, Gilbert RF, Iversen LL. Multiple opiate receptor sites on primary afferent fibres. Nature. 1980;284:351–353.
   PubMed Web of Science ®Google Scholar
• Walters AS, Wagner ML, Hening WA, et al. Successful treatment of the idiopathic restless legs syndrome in a randomized double-blind trial of oxycodone versus placebo. Sleep. 1993;167:327–332.
   Google Scholar
• Lauerma H, Markkula J. Treatment of restless legs syndrome with tramadol: an open study. J Clin Psychiatry. 1999;60:241–244.
   PubMed Web of Science ®Google Scholar
• Ondo WG. Methadone for refractory restless legs syndrome. Mov Disord. 2005;20:345–348.
   PubMed Web of Science ®Google Scholar
• Walters AS, Winkelmann J, Trenkwalder C, et al. Long-term follow-up on restless legs syndrome patients treated with opioids. Mov Disord. 2001;16:1105–1109.
   PubMed Web of Science ®Google Scholar
• Silver N, Allen RP, Senerth J, Earley CJ. A 10-year, longitudinal assessment of dopamine agonists and methadone in the treatment of restless legs syndrome. Sleep Med. 2011;12:440–444.
   PubMed Web of Science ®Google Scholar
• García-Borreguero D. Dopaminergic augmentation in restless legs syndrome/Willis-Ekbom disease: identification and management. Sleep Med Clin. 2015;10(3):287–292.
   Google Scholar
• Teichtahl H, Wang D. Sleep-disordered breathing with chronic opioid use. Expert Opin Drug Saf. 2007;6:641–649.
   PubMed Web of Science ®Google Scholar
• Bianchi MT, Goparaju B, Moro M. Sleep apnea syndrome in patients reporting insomnia or restless legs syndrome. Acta Neurol Scand. 2016;133:61–67.
   Web of Science ®Google Scholar
• Burness CB, Keating GM. Oxycodone/naloxone prolonged-release: a review of its use in the management of chronic pain while counteracting opioid-induced constipation. Drugs. 2014;74(3):353–375.
   PubMed Web of Science ®Google Scholar
• Trenkwalder C, Benes H, Grote L, et al. Prolonged release oxycodone-naloxone for treatment of severe restless legs syndrome after failure of previous treatment: a double-blind, randomised, placebo-controlled trial with an open-label extension. Lancet Neurol. 2013;12(12):1141–1150.
   PubMed Web of Science ®Google Scholar
• Walters AS, LeBrocq C, Dhar A, et al. Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Sleep Med. 2003;4:121–132.
   PubMed Web of Science ®Google Scholar
• Trenkwalder C, Beneš H, Poewe W, et al. Efficacy of rotigotine for treatment of moderate-to-severe restless legs syndrome: a randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2008;7:595–604.
   PubMed Web of Science ®Google Scholar
• Paulus W, Schomburg ED. Dopamine and the spinal cord in restless legs syndrome: does spinal cord physiology reveal a basis for augmentation? Sleep Med Rev. 2006;10:185–196.
   Web of Science ®Google Scholar